You just read:

InstaCare Subsidiary Signs New Agreement for Expanded Management and Sales of Shasta Genstrip Into the $20 Billion Worldwide Diabetes Testing Market

News provided by

InstaCare Corp.

Apr 18, 2011, 09:25 ET